Radiomics and Radiogenomics of Non-small Cell Lung Cancer

Plain-language summary

This study examined an imaging-based radiomic signature (analysis method) and its relationship with genetic information in patients with non-small cell lung cancer (NSCLC). It enrolled NSCLC patients who were candidates for assessment of their mutational status. It was a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

European Institute of Oncology

Intervention

Radiomic signature

Start date

6/12/2018

Estimated completion

9/14/2023

Countries

Italy

Related genes

Locations

• Milan, Italy

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* patients with diagnosis of NSCLC
* patients candidates for mutational status assessment

Exclusion Criteria:

\- patients with age \<18 years